The global success of mRNA medicines would not have succeeded without comprehensive analytical support. With more pressure on drug development timelines, the necessity to access novel, optimised and high-throughput analytical methods is paramount to guarantee the approval & commercialisation of safe and efficacious mRNA therapeutics & vaccines.

Industry experts naviagted through case-study-led presentations and interactive discussions to: